According to the statistics from Hong Kong Cancer Registry under Hospital Authority (HA) in 2021, there were over 35000 new cancer cases in Hong Kong in 2019, meaning that 96 people were diagnosed of cancer per day.
Breast cancer is one of the top killers of women in Hong Kong. It accounted for 13.7% of female cancer deaths in 2019. In 2018, there were more than 4,600 new cases. Ovarian cancer ranked third among female cancers. Brca stands for breast cancer gene and ovarian cancer gene. Brca gene testing is performed to predict the risk of breast cancer and ovarian cancer. Mutations in the Brca gene increase the risk of breast cancer or ovarian cancer.
Cancer is not an incurable disease. Early cancer genetic testing can help to confirm the diagnosis, make treatment decisions, and reduce the risk of cancer death.
Positive result = higher risk of having cancer
A genetic test can help to confirm diagnosis, and make treatment decisions
This test is specially designed for heritable germline mutation genes, which is unsuitable for screening somatic mutations in tumor tissues
Target group
Have a family history of breast and/or ovarian cancer
Family members confirmed to have single or multiple Brca-related cancer genes
Early onset of breast cancer (before 50 years old)
Step 1Online registration / Phone call
Step 2Provide you Name, Phone, Date of Birth, Collection date and time
Step 3Online Payment and Cash on site
Done